Armetheon Obtains $7,000,000 Series A Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bb9eb9c0-d573-4036-8294-fc8ff02efbbc
Date
8/29/2014
Company Name
Armetheon
Mailing Address
325 Sharon Park Drive Menlo Park, CA 94025 USA
Company Description
Armetheon, Inc., is a privately held San Francisco Bay area based clinical stage biopharmaceutical company focused on the development of novel drugs for highly unmet need in cardiovascular diseases. The company was founded by three successful biotech entrepreneurs and pharmaceutical executives with several years of drug R&D and company building experience.
Website
http://www.armetheon.com
Transaction Type
Venture Equity
Transaction Amount
$7,000,000
Transaction Round
Series A
Proceeds Purposes
The funds will be used to keep to our NDA filing timeline in 2017 for Tecarfarin.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor